Trump administration rebate proposal would not reduce list prices, CBO predicts

A Congressional Budget Office estimate of the cost of the Trump administration’s plans to scrap rebates to PBMs and drug plans in Medicare Part D

Read the full 251 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE